Tamoxifen reduces breast cancer by a third in high risk womenBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7365.613/a (Published 21 September 2002) Cite this as: BMJ 2002;325:613
- Susan Mayor
Tamoxifen reduces the risk of breast cancer by a third over four years in healthy women at high risk of developing the disease, a major international study has shown.
But the investigators consider that the increased risk of thromboembolism and endometrial cancers from the drug means that longer term follow up is needed before a clear recommendation can be made on its use in primary breast cancer prevention.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial